Primary Recipient

NEW YORK BLOOD CENTER, INC., THE

Amount

$251,759.00

Award Date

5/24/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

With the support of the ARRA supplement, we anticipate that the binding site(s) of NB-327 and its analogs in the HIV-1 gp41, or the determinant responsible for viral resistance to these small molecule HIV-1 fusion/entry inhibitors, will ultimately be defi